| Pomeroy D
Re: Myocardial Infarction Associated with Adderall XR and Alcohol Use in a Young Man. [JOURNAL ARTICLE]
J Am Board Fam Med 2009 September-October; 22(5):590.
Full Citation | Find Related Articles | | Cheng A, Tithecott GA, Edwards WE, et al.
The impact of the withdrawal of Adderall XR (long-acting mixed amphetamine salts) from the Canadian market on paediatric patients and their families. [Journal Article]
Paediatr Child Health 2007 May; 12(5):373-8.
Abstract | Full Citation | Find Related Articles | | Bright GM
Abuse of medications employed for the treatment of ADHD: results from a large-scale community survey. [Journal Article]
Medscape J Med 2008; 10(5):111.
Abstract | Full Citation | Find Related Articles | | Ermer JC, Shojaei A, Pennick M, et al.
Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release. [Journal Article]
Curr Med Res Opin 2007 May; 23(5):1067-75.
Abstract | Full Citation | Find Related Articles | | Wilson HK, Cox DJ, Merkel RL, et al.
Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder. [JOURNAL ARTICLE]
Arch Clin Neuropsychol 2006 Oct 16.
Abstract | Full Citation | Find Related Articles | | Wilens TE, Zusman RM, Hammerness PG, et al.
An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension. [Clinical Trial, Journal Article]
J Clin Psychiatry 2006 May; 67(5):696-702.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Spencer TJ, Abikoff HB, Connor DF, et al.
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study. [Journal Article]
Clin Ther 2006 Mar; 28(3):402-18.
Abstract | Full Citation | | Biederman J, Wigal SB, Spencer TJ, et al.
A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2006 Feb; 28(2):280-93.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Spencer TJ, Wilens TE, Biederman J, et al.
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. [Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2006 Feb; 28(2):266-79.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Findling RL, Biederman J, Wilens TE, et al.
Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Pediatr 2005 Sep; 147(3):348-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
